Tenaya Therapeutics, Inc. is a high-risk pharmaceutical company based in the United States of America. Specializing in early-stage biotechnology, Tenaya is dedicated to developing innovative therapies for heart disease. With a focus on gene therapy, cellular regeneration, and precision medicine, Tenaya aims to tackle the root causes of cardiac conditions. Improve your ESG score by investing in Tenaya Therapeutics for sustainable healthcare solutions.